InvestorsHub Logo
Followers 376
Posts 17213
Boards Moderated 3
Alias Born 03/07/2014

Re: InvestorStemCell post# 11740

Thursday, 10/30/2014 10:24:20 AM

Thursday, October 30, 2014 10:24:20 AM

Post# of 106841
"Wrong those are already deferred in warrants through this decade. Only person getting a check at BHRT is the CSO and admin staff. all cash goes to debt, clinical and lights etc./"?????

Huh? What is a "deferred warrant"?

What page of a 10-Q or 10-K filing states that only the CSO "receives a check"?? Where?

The last 10-Q had a COMPENSATION TABLE- it indicates a BASE SALARY TO BE PAID and a CASH BONUS for the CSO and CEO totaling $800K and it's to BE PAID, and if not PAID IMMEDIATELY as in CASH, then a PROMISORY NOTE for 6 months is to be issued (WITH INTEREST) which means the company then owes them MORE THAN $800K and needs the CASH TO PAY THEM WHEN THE NOTE IS DUE.

LAST 10-Q filing, end period June 30, 2104, PAGE 25:

"NOTE 13 — SUBSEQUENT EVENTS


Officer compensation

On July 28, 2014, the Company’s Board of Directors approved the 2014/2015 salary for Mike Tomas, Chief Executive Officer, at $525,000 per year, beginning July 1, 2014 with an incentive bonus ranging from $150,000 to $500,000. In addition, the Board of Directors will grant Mr. Tomas options to be determined on or before June 30, 2015. The Company’s Board of Directors approved a bonus of $500,000 and options to acquire 10,000,000 shares of the Company’s common stock for ten years with four year vesting and a cashless exercise provision at an exercise price equal to the five day average closing price of the Company’s common stock as of August 1, 2014. The cash bonus may be paid in the form a six month promissory note.

On July 28, 2014, the Company’s Board of Directors approved the 2014/2015 salary for Kristin Comella, Chief Scientific Officer, at $250,000 per year, beginning July 1, 2014 with an incentive bonus ranging from $100,000 to $300,000. In addition, the Board of Directors will grant Ms. Comella options to be determined on or before June 30, 2015. The Company’s Board of Directors approved a bonus of $300,000 and options to acquire 5,000,000 shares of the Company’s common stock for ten years with four year vesting and a cashless exercise provision at an exercise price equal to the five day average closing price of the Company’s common stock as of August 1, 2014. The cash bonus may be paid in the form a six month promissory note."

There is NO NOTES, sub text, "*" or anything else to indicate this is paid via some imagined "deferred warrants" (again, whatever that even is???) these are salaries and thus EXPENSES and fall under the SG&A entry expense line as a cost. PERIOD.

Everything in that description above as "compensation", other than STOCK OPTIONS comes from CASH, TO BE PAID, ON TIME, except the bonus, which may be delayed 6 months if that much cash is not available (which of course it was not at the time, but will be when "financing" arrives), then it gets paid as a CASH BONUS, just like the wording states.

Unless it's in the SEC filed 10-Q or 10-K and a page number can be given, then it's just all made up, IMO.